|
|
|
Search
03/02/2016 Paul Kesselman, DPM
NPs and PAs Providing Diabetic Foot Examinations (Joseph Borreggine DPM)
While I was not on this call due to a scheduling conflict, I was told that the meeting w NGS went very well. This meeting was arranged for by APMA and open to all. The presenters of NGS were members of the Provider Outreach and Education (POE) team, not auditors or a Carrier Medical Director (CMD).
Prior to this call, one week earlier, a conference call took place with Dr. Hoover (Region C CMD) and supervisory auditors from CGS along with some APMA staff and a few others selected by APMA. This call was initiated by the Georgia Carrier Advisory Committee rep, Dr. Len La Russa who himself had 12/16 claims slated to go to the ALJ pulled and ordered paid by the Supervisor of the auditing staff at CGS. She had researched these claims and found the original documentation sent for pre- payment audit, was in accordance with the LCD and ordered them paid.
He and I had discussed these issues for the last several months and thought it would be a good idea for a small select few to specifically address issues with the auditing process with appropriate personnel at CGS. Here is a summary of the discussion:
Dr. Hoover and the auditing staff allowed me to speak for several minutes, during which time I took them to task over the issues which the CAC rep and many other suppliers constantly confronted.
These included responses to the audits which clearly made no sense and which were provided based on the CAC reps experience and about 48 other examples which I had reviewed for APMA. Rejections for things such as a lack of a foot exam, when was clearly conducted by the DPM and which clearly documented 1/6 qualifying conditions and which clearly was co signed and agreed to by the managing MD/DO in a timely fashion; lack of a medical note from the MD which clearly outlined the patients DM care, etc, which clearly was provided and performed within the time constraints of the TSPD policy.
There were even several rejections for lack of a response to the audit, when it was clearly received by CGS (e.g. proof of mail delivery provided). I even took some exception to the CERT December webinar webinar and have had several respectful conversations with them regarding their findings. They have been very sympathetic and urged CGS to participate in the discussions which recently took place.
There were of course many of the 48 examples which clearly should have (and were) rejected by CGS and those illustrated to me how many DPMs still lack a clear understanding of what is required or just choose to ignore the regulations and take their chances. I readily admitted that fact and suggested that perhaps CGS still needed to do a better job of educating those asepcts of the supplier community, no matter what type of provider they are.
Dr. Hoover was very gracious on the call and he agreed with the issues I (and other APMA staff presented). He readily admitted that CGS needed to and was now doing a better job at educating the auditing staff. He suggested that in the last few months they have revved up the educating process of the auditors and results for January 2016 (and his prediction for the remainder of this first quarter) would reflect a significant difference from the last quarter of 2015.
They are basing those results on the % changes during January and saw no reason that this was not going to continue. I also suggested that any conflicting findings between Educational Review Program Auditors and those of the Pre Payment audit level would only further confuse suppliers and continue to be costly to the DME MAC's profit margin.
I also asked Dr. Hoover why statistics for any one supplier group (e.g., podiatry) could not be obtainable with regards to audit results. While BMAD data is available for different supplier types, this data does not adequately describe the rationale for claims rejections.
Furthermore, years ago, I was able to obtain that data for podiatry from Region A on a quarterly basis. Dr. Hoover thought that this data was obtainable and I am going to follow up w/him on this. This could the carriers tremendously (by saving them $$$) if they knew which supplier group needs more educating and audits targeting those who continue to fail. This ultimately would save both the carriers and the CMS $$ by selectively targeting the appropriate supplier types for more or less education and increased or less audit scrutiny. Less audits, less personnel, less expenses to draw down the carrier's net profit etc. He agreed this was a good idea and I am going to follow up w/him to see what statistics can be obtainable (possibly under FOI).
I asked several questions regarding the issue of an NP/PA signing the medical exam (not the Cert statement) and the MD/DO managing the DM signing off on the exam, with the signature of that MD/DO being dated and stating,"I was present and supervised the exam."
Dr. Hoover's response (echoed by the auditing staff):
1) A PA or NP may not perform or be a co-signature to the medical record establishing the patients diagnosis of DM. The exam must be done by an MD or DO and the MD/DO cannot simply state "I supervised and was present during the exam." This is true regardless of HSA status.
2) AN MD or DO is the only degree acceptable on the cert statement, regardless of HSA.
While the carriers are sympathetic to the issue of hardship for patients, CMD Hoover expressed what I have heard before from CMDs and CMS. Since TSPD coverage was provided through an act of Congress, any substantive changes to requirements must be accomplished by another act of Congress. A HSA area would not provide any exemptions to the rules. The only exemption that the TSPD allows for with respect to medical degrees is when Certifying physician may also be the supplier. This is only in an HSA.
There certainly was no mention of shortage areas being granted an exemption to allowing the DPM NP or PA to be the Cert physician. If anything there was significant emphasis to the contrary.
My suggestion again is if there are any discrepancies noted between the opinions presented during the webinar open to all from NGS and the limited access call w/auditors and the CMD from Region C, one should defer to that which took place with Region C. The reason being is those who participated for Region C vs. those who participated for Region B. In the past, when questions during POE calls cannot be answered by POE reps, they always defer to auditors, policy writers and the CMD. Calls like this and open dialog as was made possible by Dr. La Russa can only serve to help us provide the proper care for our patients.
Dr. La Russa deserves congratulations on a job well done!
Paul Kesselman, DPM, Woodside, NY
There are no more messages in this thread.
|
|
|
|